DermTech (DMTK) Misses Q1 EPS by 11c

DermTech (NASDAQ: DMTK) reported Q1 EPS of ($1.02), $0.11 worse than the analyst estimate of ($0.91). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $3.5 million.

For earnings history and earnings-related data on DermTech (DMTK) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Artiva Biotherapeutics, Inc. (ARTV) Misses Q2 EPS by 63c
• Minerva Neurosciences (NERV) Tops Q2 EPS by 5c